Table of Contents

1 Study Coverage

• 1.1 Pet Pharmaceuticals Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Pet Pharmaceuticals Market Size Growth Rate by Product
  • 1.4.2 Pill
  • 1.4.3 Injection
  • 1.4.4 Spray
  • 1.4.5 Ointment
  • 1.4.6 Others
• 1.5 Market by End User
  • 1.5.1 Global Pet Pharmaceuticals Market Size Growth Rate by End User
  • 1.5.2 Treatment
  • 1.5.3 Prevention
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Pet Pharmaceuticals Market Size
  • 2.1.1 Global Pet Pharmaceuticals Revenue 2014-2025
  • 2.1.2 Global Pet Pharmaceuticals Sales 2014-2025
• 2.2 Pet Pharmaceuticals Growth Rate by Regions
  • 2.2.1 Global Pet Pharmaceuticals Sales by Regions
  • 2.2.2 Global Pet Pharmaceuticals Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Pet Pharmaceuticals Sales by Manufacturers
  • 3.1.1 Pet Pharmaceuticals Sales by Manufacturers
  • 3.1.2 Pet Pharmaceuticals Sales Market Share by Manufacturers
  • 3.1.3 Global Pet Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
• 3.2 Pet Pharmaceuticals Revenue by Manufacturers
  • 3.2.1 Pet Pharmaceuticals Revenue by Manufacturers (2014-2019)
  • 3.2.2 Pet Pharmaceuticals Revenue Share by Manufacturers (2014-2019)
• 3.3 Pet Pharmaceuticals Price by Manufacturers
• 3.4 Pet Pharmaceuticals Manufacturing Base Distribution, Product Types
  • 3.4.1 Pet Pharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Pet Pharmaceuticals Product Type
  • 3.4.3 Date of International Manufacturers Enter into Pet Pharmaceuticals Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Pet Pharmaceuticals Sales by Product
• 4.2 Global Pet Pharmaceuticals Revenue by Product
• 4.3 Pet Pharmaceuticals Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Pet Pharmaceuticals Breakdown Data by End User

6 North America

• 6.1 North America Pet Pharmaceuticals by Countries
  • 6.1.1 North America Pet Pharmaceuticals Sales by Countries
  • 6.1.2 North America Pet Pharmaceuticals Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Pet Pharmaceuticals by Product
• 6.3 North America Pet Pharmaceuticals by End User

7 Europe

• 7.1 Europe Pet Pharmaceuticals by Countries
  • 7.1.1 Europe Pet Pharmaceuticals Sales by Countries
  • 7.1.2 Europe Pet Pharmaceuticals Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Pet Pharmaceuticals by Product
• 7.3 Europe Pet Pharmaceuticals by End User

8 Asia Pacific

• 8.1 Asia Pacific Pet Pharmaceuticals by Countries
  • 8.1.1 Asia Pacific Pet Pharmaceuticals Sales by Countries
  • 8.1.2 Asia Pacific Pet Pharmaceuticals Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Pet Pharmaceuticals by Product
• 8.3 Asia Pacific Pet Pharmaceuticals by End User

9 Central & South America

• 9.1 Central & South America Pet Pharmaceuticals by Countries
  • 9.1.1 Central & South America Pet Pharmaceuticals Sales by Countries
  • 9.1.2 Central & South America Pet Pharmaceuticals Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Pet Pharmaceuticals by Product
• 9.3 Central & South America Pet Pharmaceuticals by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Pet Pharmaceuticals by Countries
  • 10.1.1 Middle East and Africa Pet Pharmaceuticals Sales by Countries
  • 10.1.2 Middle East and Africa Pet Pharmaceuticals Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Pet Pharmaceuticals by Product
• 10.3 Middle East and Africa Pet Pharmaceuticals by End User

11 Company Profiles

• 11.1 Zoetis
  • 11.1.1 Zoetis Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Zoetis Pet Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Zoetis Pet Pharmaceuticals Products Offered
  • 11.1.5 Zoetis Recent Development
• 11.2 Merck Animal Health
  • 11.2.1 Merck Animal Health Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Merck Animal Health Pet Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Merck Animal Health Pet Pharmaceuticals Products Offered
  • 11.2.5 Merck Animal Health Recent Development
• 11.3 Merial
  • 11.3.1 Merial Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Merial Pet Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Merial Pet Pharmaceuticals Products Offered
  • 11.3.5 Merial Recent Development
• 11.4 Elanco
  • 11.4.1 Elanco Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Elanco Pet Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Elanco Pet Pharmaceuticals Products Offered
  • 11.4.5 Elanco Recent Development
• 11.5 Bayer
  • 11.5.1 Bayer Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Bayer Pet Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Bayer Pet Pharmaceuticals Products Offered
  • 11.5.5 Bayer Recent Development
• 11.6 Boehringer Ingolheim
  • 11.6.1 Boehringer Ingolheim Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Boehringer Ingolheim Pet Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Boehringer Ingolheim Pet Pharmaceuticals Products Offered
  • 11.6.5 Boehringer Ingolheim Recent Development
• 11.7 Novartis
  • 11.7.1 Novartis Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Novartis Pet Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Novartis Pet Pharmaceuticals Products Offered
  • 11.7.5 Novartis Recent Development
• 11.8 Virbac Group
  • 11.8.1 Virbac Group Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Virbac Group Pet Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Virbac Group Pet Pharmaceuticals Products Offered
  • 11.8.5 Virbac Group Recent Development
• 11.9 Ceva Sante Animale
  • 11.9.1 Ceva Sante Animale Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Ceva Sante Animale Pet Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Ceva Sante Animale Pet Pharmaceuticals Products Offered
  • 11.9.5 Ceva Sante Animale Recent Development
• 11.10 Vétoquinol S.A.
  • 11.10.1 Vétoquinol S.A. Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Vétoquinol S.A. Pet Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Vétoquinol S.A. Pet Pharmaceuticals Products Offered
  • 11.10.5 Vétoquinol S.A. Recent Development

12 Future Forecast

• 12.1 Pet Pharmaceuticals Market Forecast by Regions
  • 12.1.1 Global Pet Pharmaceuticals Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Pet Pharmaceuticals Revenue Forecast by Regions 2019-2025
• 12.2 Pet Pharmaceuticals Market Forecast by Product
  • 12.2.1 Global Pet Pharmaceuticals Sales Forecast by Product 2019-2025
  • 12.2.2 Global Pet Pharmaceuticals Revenue Forecast by Product 2019-2025
• 12.3 Pet Pharmaceuticals Market Forecast by End User
• 12.4 North America Pet Pharmaceuticals Forecast
• 12.5 Europe Pet Pharmaceuticals Forecast
• 12.6 Asia Pacific Pet Pharmaceuticals Forecast
• 12.7 Central & South America Pet Pharmaceuticals Forecast
• 12.8 Middle East and Africa Pet Pharmaceuticals Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Pet Pharmaceuticals Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Pet Pharmaceuticals market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pet Pharmaceuticals market based on company, product type, end user and key regions.

This report studies the global market size of Pet Pharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pet Pharmaceuticals in these regions.
This research report categorizes the global Pet Pharmaceuticals market by top players/brands, region, type and end user. This report also studies the global Pet Pharmaceuticals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Zoetis
Merck Animal Health
Merial
Elanco
Bayer
Boehringer Ingolheim
Novartis
Virbac Group
Ceva Sante Animale
Vétoquinol S.A.

Market size by Product
Pill
Injection
Spray
Ointment
Others
Market size by End User
Treatment
Prevention

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Pet Pharmaceuticals market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pet Pharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pet Pharmaceuticals companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pet Pharmaceuticals submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pet Pharmaceuticals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pet Pharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.